With 17 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $18.86B. The average expense ratio is 0.69%. Biotech ETFs can be found in the following asset classes:
The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $9.14B in assets. In the last trailing year, the best performing Biotech ETF was the LABU at 60.75%. The most-recent ETF launched in the Biotech space was the Global X China Biotech Innovation ETF CHB in 09/22/20.